Line 8: | Line 8: | ||
<div class="container-fluid"> | <div class="container-fluid"> | ||
− | <!-- Section | + | <!-- Section 1 --> |
<div class="row" id="projintro" style="padding-top:0px;"> | <div class="row" id="projintro" style="padding-top:0px;"> | ||
<div class="col-md-14 content" style="max-width:1000px;padding:10px 50px;"> | <div class="col-md-14 content" style="max-width:1000px;padding:10px 50px;"> | ||
Line 34: | Line 34: | ||
</div></br> | </div></br> | ||
</div> <!-- End of projintro --> | </div> <!-- End of projintro --> | ||
− | <!-- End of Section | + | <!-- End of Section 1 --> |
− | <!-- Section | + | <!-- Section 2 --> |
<div class="row" id="teamintro" style="Background:#f6f6f6;"> | <div class="row" id="teamintro" style="Background:#f6f6f6;"> | ||
</br><h3 style="padding-top:0px;">Our Goals</h3> | </br><h3 style="padding-top:0px;">Our Goals</h3> | ||
Line 53: | Line 53: | ||
</div> <!-- End of teamintro --> | </div> <!-- End of teamintro --> | ||
</div> <!-- End of Container-Fluid --> | </div> <!-- End of Container-Fluid --> | ||
− | <!-- End of Section | + | <!-- End of Section 2 --> |
− | <!-- Section | + | <!-- Section 3 --> |
+ | <div class="row" id="teamintro" style="Background:#ddd;"> | ||
+ | </br></br><h3 style="padding-top:0px;">Aim 1</h3> | ||
+ | <div class="col-md-14 content" style="max-width:1000px;padding:10px 50px;"> | ||
+ | Content | ||
+ | </div> <!-- End of col-md-14 --> | ||
+ | </br></br><div class="col-md-2"></div> | ||
+ | </div> <!-- End of teamintro --> | ||
+ | </div> <!-- End of Container-Fluid --> | ||
+ | <!-- End of Section 3 --> | ||
+ | |||
+ | <!-- Section 4 --> | ||
+ | <div class="row" id="teamintro" style="Background:#ddd;"> | ||
+ | </br></br><h3 style="padding-top:0px;">Aim 2</h3> | ||
+ | <div class="col-md-14 content" style="max-width:1000px;padding:10px 50px;"> | ||
+ | Content | ||
+ | </div> <!-- End of col-md-14 --> | ||
+ | </br></br><div class="col-md-2"></div> | ||
+ | </div> <!-- End of teamintro --> | ||
+ | </div> <!-- End of Container-Fluid --> | ||
+ | <!-- End of Section 4 --> | ||
+ | |||
+ | <!-- Section 5 --> | ||
+ | <div class="row" id="teamintro" style="Background:#ddd;"> | ||
+ | </br></br><h3 style="padding-top:0px;">Aim 3</h3> | ||
+ | <div class="col-md-14 content" style="max-width:1000px;padding:10px 50px;"> | ||
+ | Content | ||
+ | </div> <!-- End of col-md-14 --> | ||
+ | </br></br><div class="col-md-2"></div> | ||
+ | </div> <!-- End of teamintro --> | ||
+ | </div> <!-- End of Container-Fluid --> | ||
+ | <!-- End of Section 5 --> | ||
+ | |||
+ | <!-- Section 6 --> | ||
+ | <div class="row" id="teamintro" style="Background:#ddd;"> | ||
+ | </br></br><h3 style="padding-top:0px;">Conclusion</h3> | ||
+ | <div class="col-md-14 content" style="max-width:1000px;padding:10px 50px;"> | ||
+ | Content | ||
+ | </div> <!-- End of col-md-14 --> | ||
+ | </br></br><div class="col-md-2"></div> | ||
+ | </div> <!-- End of teamintro --> | ||
+ | </div> <!-- End of Container-Fluid --> | ||
+ | <!-- End of Section 6 --> | ||
+ | |||
+ | <!-- Section 7 --> | ||
+ | <div class="row" id="teamintro" style="Background:#ddd;"> | ||
+ | </br></br><h3 style="padding-top:0px;">Gold Medal Part Improvement</h3> | ||
+ | <div class="col-md-14 content" style="max-width:1000px;padding:10px 50px;"> | ||
+ | Content | ||
+ | </div> <!-- End of col-md-14 --> | ||
+ | </br></br><div class="col-md-2"></div> | ||
+ | </div> <!-- End of teamintro --> | ||
+ | </div> <!-- End of Container-Fluid --> | ||
+ | <!-- End of Section 7 --> | ||
+ | |||
+ | <!-- Section 8 --> | ||
<!-- Project Start --> | <!-- Project Start --> | ||
<div class="row" id="teamintro" style="Background:#eee;"> | <div class="row" id="teamintro" style="Background:#eee;"> | ||
Line 71: | Line 126: | ||
</div> <!-- End of Container-Fluid --> | </div> <!-- End of Container-Fluid --> | ||
+ | <!-- End of Section 8 --> | ||
</body> | </body> |
Revision as of 00:34, 20 October 2016
Project Overview
In 2010 it was estimated that 6.5 million people in the United States alone suffered from chronic wounds, accruing an annual cost of approximately $2.5 billion. Furthermore, experts predict that the burden of chronic wounds will increase rapidly in the near future due to increasing medical costs, an aging population, and the emergence of antibiotic resistant bacteria. Chronic wounds are characterized by their inability to progress through an orderly set of stages within a time period of about three months. Wound healing progresses through four successive stages known as hemostasis, inflammation, proliferation and remodeling.Our Goals
We will use synthetic biology principles to help treat chronic wounds by targeting the overproduction of wound site protease.
- For Aim 1 we will genetically engineer E. coli to produce a protease inhibitor and platelet derived growth factor.
- For Aim 2 we will purify the protease inhibitor and platelet derived growth factor in a bioreactor.
- For Aim 3 we will design a collagen bandage that mimics the human extracellular matrix, and infuse it with purified protease inhibitor and platelet derived growth factor.
Aim 1
Content
Aim 2
Content
Aim 3
Content
Conclusion
Content